FDA Announces Hearing on Genetically Engineered Salmon Labeling
The Food and Drug Administration is announcing a public hearing on September 21, 2010 in Rockville, MD regarding the labeling of food derived from AquAdvantage Salmon, a genetically engineered Atlantic salmon.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.